Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson’s disease

Translational Psychiatry

Volumn 6, Issue 2, 2016, Pages

  Lauretti, E ^a   Di Meco, A ^a   Merali, S ^b   Pratico D ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; PALLADIUM; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BEHAVIORAL STRESS; BIOCHEMICAL ANALYSIS; BRAIN REGION; C57BL 6 MOUSE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; GENETIC RISK; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMOBILIZATION STRESS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATENCY TO FALL; LEARNING; LOCOMOTION; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARKINSON DISEASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; ROTAROD TEST; SUBSTANTIA NIGRA; ANIMAL; ANIMAL BEHAVIOR; BRAIN; C57BL MOUSE; CHRONIC DISEASE; COMPLICATION; DISEASE MODEL; FEMALE; INFLAMMATION; MALE; MENTAL STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MOTOR DISORDERS; PARKINSON DISEASE; STRESS, PSYCHOLOGICAL;

EID: 85007372935     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2016.1     Document Type: Article

References (19)

1. Shiotsuki H, Yoshimi K, Shimo Y, Funayama M, Takamatsu Y, Ikeda K et al. A rotarod test for evaluation of motor skill learning. J Neurosci Methods 2010; 189: 180–185.
2. Speciale SG. MPTP: insights into parkinsonian neurodegeneration. Neurotoxicol Teratol 2002; 24: 607–620.
3. Kibel A, Drenjancević-Perić I. Impact of glucocorticoids and chronic stress on progression of Parkinson's disease. Med Hypotheses 2008; 71: 952–956.
4. Gil M, Armario A. Chronic immobilization stress appears to increase the role of dopamine in the control of active behavior in the forced swimming test. Behav Brain Res 1998; 91: 91–97.
5. Sedelis M, Schwarting RK, Huston JP. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav Brain Res 2001; 125: 109–125.
6. Kim ST, Choi JH, Chang JW, Kim SW, Hwang O. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J Neurochem 2005; 95: 89–98.
7. Tieu K. A guide to neurotoxic animal models of Parkinson's disease. Cold Spring Harb Perspect Med 2011; 1: a009316.
8. Joshi YB, Giannopoulos PF, Chu J, Sperow M, Kirby LG, Abood ME et al. Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in a mouse model of Alzheimer's disease. Hum Mol Genet 2014; 23: 6894–6902.
9. Coppi A, Merali S, Eichinger D. The enteric parasite Entamoeba uses an autocrine catecholamine system during differentiation into the infectious cyst stage. J Biol Chem 2002; 277: 8083–8090.
10. Merali S, Clarkson AB. Polyamine analysis using N-hydroxysuccinimidyl-6-amino-quinoyl carbamate for pre-column derivatization. J Chromatogr B Biomed Sci Appl 1996; 675: 321–326.
11. Di Meco A, Joshi YB, Praticò D. Sleep deprivation impairs memory, tau metabo-lism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles. Neurobiol Aging 2014; 35: 1813–1820.
12. Lauretti E, Di Meco A, Chu J, Praticò D. Modulation of AD neuropathology and memory impairments by the isoprostane F2α is mediated by the thromboxane receptor. Neurobiol Aging 2014; 36: 812–820.
13. Brooks SP, Dunnett SB. Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci 2009; 10: 519–529.
14. Lim MM, Xu J, Holtzman DM, Mach RH. Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum. Neuroreport 2011; 22: 489–493.
15. Haavik J, Toska K. Tyrosine hydroxylase and Parkinson's disease. Mol Neurobiol 1998; 16: 285–309.
16. Smith LK, Jadavji NM, Colwell KL, Katrina Perehudoff S, Metz GA. Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease. Eur J Neurosci 2008; 27: 2133–2146.
17. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011; 63: 182–217.
18. Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson's disease. Brain Res Mol Brain Res 2005; 134: 57–66.
19. Rappold PM, Tieu K. Astrocytes and therapeutics for Parkinson's disease. Neu-rotherapeutics 2010; 7: 413–423.